Afatinib in Advanced NRG1-Rearranged Malignancies

Clinical trial NCT04410653 · COMPLETED

Trial details

NCT number: NCT04410653
Sponsor: German Cancer Research Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic and Locally Advanced NRG1-rearranged Malignancies

Start date: 2022-07-31
Primary completion: 2023-10-04
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.